Research

Publications
  1. First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

    Komdeur, F. L., Singh, A., van de Wall, S., Meulenberg, J. J. M., Boerma, A., Hoogeboom, B. N., Paijens, S. T., Oyarce, C., de Bruyn, M., Schuuring, E., Regts, J., Marra, R., Werner, N., Sluis, J., van der Zee, A. G. J., Wilschut, J. C., Allersma, D. P., van Zanten, C. J., Kosterink, J. G. W., Jorritsma-Smit, A., Yigit, R., Nijman, H. W. & Daemen, T., 2020, (Accepted/In press) In : Molecular Therapy.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccine based on recombinant viral particles

    Jorritsma-Smit, A., van Zanten, C. J., Schoemaker, J., Meulenberg, J. J. M., Touw, D. J., Kosterink, J. G. W., Nijman, H. W., Daemen, T. & Allersma, D. P., 15-Feb-2020, In : European Journal of Pharmaceutical Sciences. 143, 8 p., 105096.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (22) »

ID: 463816